HB4Y1B

Sample exhibits significant inhibitory activity against Streptococcus pneumoniae and Cryptococcus neoformans, and moderate activity against Neisseria gonorrhoeae.

Specialized in Streptococcus pneumoniae, a Gram-positive bacterium that can cause severe respiratory infections, and Cryptococcus neoformans, an opportunistic pathogen associated with meningitis in immunocompromised patients, with moderate action against Neisseria gonorrhoeae, suggesting potential therapeutic use in sexually transmitted infections. This fraction has the potential to address a wide variety of bacterial and fungal infections, making a difference in the treatment of infectious diseases.

The inhibitory activity of HB4Y1B against these three pathogens is very promising, targeting its potential for the development of new effective drugs against these infections. These results underline the importance of research in the search for therapeutic compounds that can effectively combat both bacterial and fungal infections.

Know more about the pathogens